SI
ALXN

Scharf Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Scharf Investments’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-457,897
Closed -$84.1M – 51
2021
Q2 		$84.1M Sell
457,897
-83,762
-15% -$14.4M 2.55% 20
2021
Q1 		$82.8M Buy
541,659
+2,900
+0.5% +$449K 2.87% 20
2020
Q4 		$84.2M Sell
538,759
-10,965
-2% -$1.41M 3.17% 18
2020
Q3 		$62.9M Sell
549,724
-22,473
-4% -$2.42M 2.71% 18
2020
Q2 		$64.2M Buy
572,197
+2,852
+0.5% +$303K 2.88% 17
2020
Q1 		$51.1M Buy
+569,345
New +$55.9M 2.56% 20

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return